F-18-Fluorodeoxyglucose Positron Emission Tomography Imaging-Assisted Management of Patients With Severe Left Ventricular Dysfunction and Suspected Coronary Disease

Rob S. B. Beanlands, MD, FRCPC, FACC,* Graham Nichol, MD, FRCPC,†† Ella Huszti, MSC,¶ Dennis Humen, MD, FRCPC, FACP, FACC,† Normand Racine, MD, FRCPC,# Michael Freeman, MD, FACC, FRCPC,‡ Karen Y. Gulenchyn, MD, FRCPC, Linda Garrard, BSC, RN,* Robert deKemp, PHD,* Ann Guo, MENG,* Terrence D. Ruddy, MD, FRCPC, FACC,* Francois Benard, MD, FRCPC,** André Lamy, MD, MHSC, Robert M. Iwanochko, MD, FRCPC, FACC,§ and the PARR-2 Investigators‡‡ Ottawa, London, Toronto, and Hamilton, Ontario, Canada; Montréal, Sherbrooke, and Québec City, Quebec, Canada; and Seattle, Washington